Low back pain is the leading worldwide cause of years lost to disability and its burden is growing alongside the increasing and ageing population. 1 Because these population shifts are more rapid in low-income and middle-income countries, where adequate resources to address the problem might not exist, the effects will probably be more extreme in these regions. Most low back pain is unrelated to specific identifiable spinal abnormalities, and our Viewpoint, the third paper in this Lancet Series, 2,3 is a call for action on this global problem of low back pain.
The panel summarises the most pressing political, public health, and health-care challenges and identifies actions to meet them. Prevention of the onset and persistence of disability associated with low back pain requires recognition that the disability is inseparable from the social and economic context of people's lives and is entwined with personal and cultural beliefs about back pain. 4 Health and workplace policies and disability payment systems are often ineffective and wasteful, and they are key targets for improvements. Socioeconomically disadvantaged people are overrepresented among those with disabling low back pain. 5 In many settings they will be further disadvantaged by restricted access to accurate information sources, health-care approaches that provide appropriate support for self-management of uncomplicated low back pain, and to specialised effective interventions, such as multidisciplinary rehabilitation, for complex persistent low back pain.
Public health programmes that tackle obesity and low levels of physical activity might provide a model and structure for reducing the effects of low back pain on daily life, 6 although independent associations between the life-style issues and low back pain are uncertain. Implementation of these programmes is especially urgent in some low-income and middle-income countries where increasing obesity rates and rapid industrial growth and consequent reductions in physical activity are occurring in urban areas. Health system and societal initiatives addressing low back pain should act in synergy with the WHO European Region action plan for the prevention and control of non-communicable diseases, which recognises the need for comprehensive promotion of musculoskeletal health. Because low back pain disability often affects employability in the informal sector, integration between health, workplace, and social services should also be a key goal.
Disabling low back pain is partly iatrogenic. Studies in low-income countries and Indigenous and assimilated populations in high-income countries show that exposure to health care can sometimes have harmful consequences. [7] [8] [9] Such negative effects of health care reflect a change in views, from low back pain being a fairly benign part of daily life, to it being seen as a problem requiring medical attention. Increased use of ineffective potentially unsafe treatments has wasted limited health-care resources and harmed patients. The epidemic of addiction and rising mortality resulting from increased opioid prescribing in the USA over the past 20 years is a dramatic example of the disastrous effects of damaging medical intervention. 10 In low-income and middle-income countries, epidemiological evidence suggests that improving social and economic conditions could prevent or reduce incidence of low back pain, but could also create expectations and demands for medical investigations and low-value health care that paradoxically increase the risk of long-term back-related disability (what we term the low back pain paradox).
The global challenge is to prevent the use of practices that are harmful or wasteful while ensuring equitable access to effective and affordable health care for those who need it. High rates of advice to rest and use of ineffective treatments are already a reality in low-income and middleincome countries. Over-medicalisation disproportionately affects the wealthy minority, but it also threatens to reduce availability of high-value health-care services for the poor majority and further widen health and social disparities. Contextual factors, such as scarcity of suitable work, might also mean that advice that would be regarded as appropriate in high-income countries, such as encouragement to remain in work or return to work early, might not always be appropriate-or even an option-in low-income or middle-income countries.
Protection of the public from unproven or harmful approaches to managing low back pain requires that • Use the notion of positive health-the ability to adapt and to self-manage in the face of social, physical and emotional challenges-for the treatment of non-specific low back pain • Avoid harmful and useless treatments by adopting a framework similar to that used in drug regulation-ie, only include treatments in public reimbursement packages if evidence shows that they are safe, effective, and cost-effective • Address widespread misconceptions in the population and among health professionals about the causes, prognosis, and effectiveness of different treatments for low back pain, and deal fragmented and outdated models of care • Policy, public health, health-care practice, social services, and workplaces must jointly tackle the low back pain paradox in low-income and middle-income countries, where improving social and economic conditions could prevent or reduce low back pain incidence, but at the same time create expectations and demands for medical investigations and low-value health care that increase the risk of long-term back-related disability Some countries are testing these approaches. In Australia, a clinician-led taskforce is reviewing all government-subsidised tests and procedures, with the aim of removing funding for those that are unnecessary, outdated, or potentially unsafe. In the Netherlands, unproven interventions are conditionally included in the public health insurance package only if there is evidence from high quality randomised controlled trials to inform a final decision that show whether or not the intervention is efficacious and safe. Stakeholders, including patients, agree to design and eligibility criteria for the assessment. Because radio frequency denervation for patients with chronic low back pain does not provide clinically significant added benefit compared with a standardised exercise programme alone, it is no longer covered in the public health insurance package. 11 Awareness of the biopsychosocial model of low back pain has greatly advanced the understanding of the prognostic significance of psychosocial factors in individual patients. The model has had less success in shifting practitioners away from managing patients within a biomedical framework. The importance of behavioural approaches to back pain management does not preclude the continuing need to investigate mechanisms and potential biological determinants of non-specific low back pain in phenotypically distinct subgroups.
We propose adoption of the so-called positive health concept as the overarching strategic approach to the prevention of long-term disability from low back pain. 12 Positive health, as proposed by Huber and colleagues, is "the ability to adapt and to self-manage, in the face of social, physical, and emotional challenges". This term encompasses a much broader idea of health than simply absence of disease and its emphasis on medicalisation and cure.
Evidence suggests that prevalence of long-term disabling low back pain could be reduced by adopting this positive health approach. 13, 14 For health professionals, positive health focuses on alternatives to treatments and cures and promotes high-quality, meaningful lives for people with persistent low back pain. Public and patients' expectations need to change, so that people are less likely to expect a diagnosis or complete cure for their pain. This adjustment of attitude requires initiatives to change widespread and inaccurate beliefs about back pain, 13 helping future generations to avoid counterproductive patterns of illness behaviour, eg, prolonged rest, avoidance of usual activities, or staying away from work.
For people with persistent low back pain, positive health entails learning how to cope with a long-term health problem through self-management activities, and learning to seek health care only when needed. Passive approaches such as rest and medication are linked with worsening disability, whereas active strategies such as exercise are associated with reduced disability and less reliance on formal health care. Many behavioural and cognitive strategies are used by people with chronic pain in the community, regardless of whether or not they seek care. 15 In the occupational setting, interventions focusing on positive health, including peer support for the notion that low back pain is not an injury in need of medical treatment, 16 and redirecting problem-solving efforts away from seeking cures and towards improved individual adaptation to the pain, yield beneficial outcomes. 17 Improved training and support of primary care doctors and other professionals engaged in activity and lifestyle facilitation, such as physiotherapists, chiropractors, nurses, and community workers, could minimise the use of unnecessary medical care. Crucial to changing behaviour and improving delivery of effective care are system changes that integrate and support health professionals from diverse disciplines and care settings to provide patients with consistent messages about mechanisms, causes, prognosis and natural history of low back pain, as well as the benefits of physical activity and exercise. Traditional healers, where integrated into the health-care system, community health workers, and family remain important providers of lower cost basic education and care in many low-income countries for most people with low back pain who do not require medical attention. 18 In rural and remote regions rehabilitation advice and support given online, combined with self-management, might be an option where internet access is available.
The success of a positive health approach will depend on whether relevant stakeholders share the same mission, vision, and objectives and on the success of strategies for knowledge transfer and exchange. The appendix lists information that well informed consumers, patients, clinicians, and policy makers should know about low back pain and its global burden.
Policy makers in all countries should look to local stakeholders to help decide what overall strategies should be put in place. Similar to other areas of research lowincome and middle-income countries should ensure that investment in musculo skeletal services is effective for patients and does not damage local health systems. 19 Local participation and ownership, integration with existing priorities and policies, and coordination with national and regional systems and processes are crucial.
Funding for low back pain research is inadequate and uncoordinated. This scarcity of funds especially affects low-income and middle-income countries, where the effects of disabling low back pain remain under-recognised See Online for appendix Viewpoint and research priorities and funding remain focused on infectious diseases. One way forward would be to establish a global network of researchers from developed and developing countries, pooling experience and knowledge and building research capacity where it is needed.
The appendix lists major research priorities, which align with those previously identified by the international low back pain primary care research community. 20 Implementation research is necessary in all countries to ascertain how best to use existing knowledge and evidence through changes in patient and clinician behaviour and health system design. For low-income and middle-income countries, priorities include identifying interventions that are optimal in the context of the social, political, cultural, and health-resource factors. Although available evidencebased guidelines might be well suited for high-income countries and highly developed health-care systems, they might need adaptation to assure feasibility and cultural appropriateness for low-resource settings.
An active ongoing monitoring system is crucial to assess the effects of new strategies on outcomes such as disability, ability to work, and social participation. There is a pressing need for surveys and health-care databases in different countries that use common metrics for measuring the burden of low back pain, use of active selfmanagement strategies such as exercise, tests, and treatments, and outcomes and costs of care. The appendix shows a set of indicators of success for surveillance. Uniform data collection would encourage benchmarking of health services within and across countries. Standardised definitions of low back pain for prevalence studies have already been developed and incorporated into the Global Alliance for Musculoskeletal Health Surveillance Taskforce survey module for musculoskeletal conditions. Action is needed to address the growing burden of low back pain on many millions of people worldwide. Future social changes, including ageing, urbanisation, increasingly sedentary lifestyles, and the development of new technologies, will probably exacerbate this problem. For example, the use of increasingly sensitive imaging techniques, such as MRI, can reveal findings that might be incorrectly inferred to be the cause of a patient's symptoms.
Improved recognition of the growing burden of low back pain is essential to stimulate new, more effective, strategies of prevention and care. The effects of disabling low back pain can be reduced through social change that supports full participation in daily life. In low-income and middleincome countries, the paradox of low back pain needs to be addressed. Other barriers to optimal evidence-based management include widespread misconceptions of the general public and health professionals about the causes and prognosis of low back pain and the effectiveness of different treatments, fragmented and outdated models of care, and the widespread use of ineffective and harmful care, particularly in countries regarded as models of high quality care.
We have described actions all countries can take to reduce the effect of disabling low back pain on their populations. Strong and coordinated political action from international and national policy makers, including WHO and research funding agencies, is needed. Such action could substantially reduce disability and suffering and improve the effectiveness and efficiency of care for people with low back pain throughout the world.
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